Raanana, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd., a pre-clinical-stage biotechnology company developing intranasal protective solutions, announced today that it has submitted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback